Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Brain+ A/S appoints Anders Härfstrand as new Chairman of the Board

Company Announcement Monday, September 5, 2022, 10:00 CET The information communicated in this announcement is “inside information” for the purposes of article 7 of the Market Abuse Regulation 596/2014 Brain + A/S (“Brain+”) today announced Anders Härfstrand, who was elected to the board of directors at the company’s Extraordinary General Meeting on September 2, 2022, has been appointed new Chairman of the Board.  Anders Härfstrand has extensive international life science industry and leadership experience, and succeeds Lars Terney, who continues on the board as Vice Chairman after

Visma enters France through acquisition of cloud accounting software company Inqom

Visma, one of Europe’s leading providers of mission critical software, has signed an agreement to acquire Paris-based Inqom. Inqom offers software that automates accounting processes through artificial intelligence, and employs a team of close to 100 professionals. A successful transaction will constitute Visma’s first market entry into France, expanding the company’s presence to 29 countries across Europe and Latin America. “We are thrilled to announce our arrival in the French market by investing in Inqom. Like Visma, they develop unique technology to help customers become more

Saab’s MSHORAD System Successfully Demonstrated with Live Firing

Saab has conducted the first Mobile Short-Range Air Defence (MSHORAD) live system firing for an audience of various national delegations. In a series of firings, the system identified, tracked and engaged several targets.The firings took place during August 30 in Karlskoga, Sweden. Potential customers from 15 nations attended the live firing. A total of five successful firings were performed from the RBS 70 NG Mobile Firing Unit on the MARS-S330 vehicle against a variety of targets, including a drone and an elevated helicopter airframe. During one firing scenario the vehicle mounted sight

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NR. 174 - 5 SEPTEMBER 2022 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 158/22. A/S Motortramp participates in NORDEN’s share buy-back program by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in NORDEN.     Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor

DAMPSKIBSSELSKABET NORDEN A/S – weekly report on share buy-back

ANNOUNCEMENT NO. 173 - 5 SEPTEMBER 2022 On 18 August 2022, NORDEN initiated a share buy-back programme in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buy-back programme runs from 18 August 2022 up to and including no later than 1 November 2022. For details, please see announcement no. 158 of 18 August 2022.   Under the share buy-back programme, NORDEN will purchase shares for up to a total of USD 40 million (approximately DKK 290 million)

PharmNovo appoints CFO and Clinical Lead to strengthen the organisation

PharmNovo AB, a Swedish pharmaceutical company developing drugs for neuropathic pain, announces that the company has strengthened the team entering the clinical phase. Tommy Nilsson takes on the role of CFO, and Jarkko Kalliomäki will support clinical management and work with the design and development of clinical studies.In August, PharmNovo started clinical studies of its drug candidate PN6047 for the treatment of neuropathic pain, so-called nerve pain, after raising SEK 73 million in a share issue led by Sciety earlier this summer. Tommy Nilsson has a background as CFO at subsidiaries

Wärtsilä propulsion solution selected for sustainable new hybrid tug

Wärtsilä Corporation, Trade Press Release, 5 September 2022 at 10.30 AM EESTThe technology group Wärtsilä will supply its advanced thruster solution for a new hybrid tug being built to operate in the port of Xiamen in China. The Wärtsilä thrusters  selected have been especially designed for electric propulsion , and support the sustainability requirements of the vessel. The tug is under construction for Xiamen Port Shipping at the Fujian Mawei Shipbuilding yard. The order with Wärtsilä was placed in June 2022 by Shanghai CSIC Marine

Wyld Networks and Bayer Crop Science deploy the world’s first hive lid contact sensor

Virtual satellite operator Wyld Networks today announce the deployment of contact sensors integrated with Wyld Connect, designed and developed by Wyld Networks with Bayer Crop Sciences entomology team, to deliver hive interaction data to the global apiculture sector.The first prototype IoT beehive lid contact sensors in North America have been installed on hives in North Carolina and are now uploading data automatically. The first install was in France and more units will be deployed in 2022 on beehives in Utah, Missouri, and the Varroa-free island of Newfoundland, Canada.  The UN’s

Eitrium expands to Norway and acquires Minitech AS and its subsidiary Minitech Sweden AB

Eitrium has acquired all shares in Minitech AS and its subsidiary Minitech Sweden AB, a manufacturer of medical heating products intended for medical purposes as well as outdoor activity. The sellers will continue to operate Minitech AS and Minitech Sweden AB to ensure the continuation of its way of doing business.The Hamar-based company develops and manufactures medical heating products for institutions and orthopedic clinics within the public as well as the private sector, primarily in Norway but also in other Nordic countries. The products consist of heat regulating clothing items and

Onboard Carbon Capture Explored by ABS

Insight and Analysis on Current Technologies, CO\2\ Handling and Storage as well as Regulatory Challenges (HOUSTON) Emerging onboard carbon capture technology is explored in a new publication from ABS in its latest support for the maritime energy transition. Launched at the global trade fair for Shipbuilding, Machinery and Marine Technology (SMM), Insights into Onboard Carbon Capture examines the various methods of onboard carbon capture as well as carbon handling and storage and downstream considerations, as well as regulatory issues. “Although there has been increased

BioStock: Promore Pharma advancing according to plan

The reporting season is in full swing, and biopharmaceutical company Promore Pharma has now joined the list of companies that have reported on the second quarter. CEO Jonas Ekblom emphasises that the first months of the year have been characterised by intensive work that has resulted in the company advancing its two candidates according to plan. BioStock took the opportunity to ask Ekblom three quick questions about the report.Read the article at biostock.se: https://www.biostock.se/en/2022/09/promore-pharma-advancing-according-to-plan/ This is a press release from BioStock -

Fazer’s Master Confectioner Eero Paulamäki is preparing for the world’s fiercest chocolate competition

Fazer’s Master Confectioner Eero Paulamäki will represent the Nordic and Baltic countries in the final of the World Chocolate Masters competition in October 2022 in Paris. The talented chocolate expert’s qualification to the final brings great joy and honour also to Fazer as Paulamäki is the first ever Finnish finalist in the competition.World Chocolate Masters is the world’s leading competition in the chocolate industry. The competitors are evaluated by their technical chocolate-handling skills, creativity, and the ability to combine modern trends with traditional craftmanship. The

SOTKAMO SILVER OY WILL START CHANGE NEGOTIATIONS

Press release: Stockholm, September 5, 2022, 08:45 CET Sotkamo Silver Oy is starting the Change Negotiations in accordance with the Act on Cooperation with Undertakings in order to adapt its operations to the prevailing general economic and market situation. The scope of the Change Negotiations includes the Company's entire personnel, ca. 50 people. The sharply increased prices of energy and consumables and the simultaneous decline of the metal prices, as well as the great uncertainty and volatility associated with them, require measures to ensure the profitability of production and

Ex-Penneo CEO Niels Henrik Rasmussen becomes new CEO at Donkey Republic

Company announcement no 13-2022 ·Donkey Republic Board of Directors appoints Niels Henrik Rasmussen as new CEO, replacing co-founder Erdem Ovacik ·Niels Henrik Rasmussen, former CEO for Penneo and Secunia, is hired to continue the development and growth of Donkey Republic following the IPO last year. ·Erdem Ovacik will stay in the company in an active role as an Executive Board MemberThe Board of Directors has decided to bring in new management competencies to strengthen and professionalize the company further and has therefore appointed Niels Henrik Rasmussen as new

Atlas Copco has acquired a German company specialized in online sales of compressed air solutions

Nacka, Sweden, September 5, 2022: Atlas Copco has acquired DF-Druckluft-Fachhandel GmbH, a German online platform for compressed air solutions, and service provider.DF-Druckluft-Fachhandel GmbH is a privately owned company with 39 employees located in Herrenberg, Stuttgart, with presence in Germany and Austria. The company was founded in 2010 and provides compressed air solutions and consulting for various application segments. “DF-Druckluft-Fachhandel is a well-established company with proven expertise in online sales of compressed air solutions and equipment, making them a good fit for

STOREBRAND ASA: Storebrand strengthens its retail savings offering by acquiring Kron

Storebrand ASA has entered into an agreement to acquire the Norwegian fintech company Kron AS ("Kron"). "Kron has been successful in creating enthusiasm for savings and investments through their digital application for mutual funds and pensions. Kron's user experience together with Storebrand's product expertise and strong distribution power is an attractive combination for new and existing customers. This is perfect match," says Storebrand's CEO, Odd Arild Grefstad. "Together, we will continue to create even better solutions and reach out to even more people. We will continue to

Buybacks of shares by H&M during week 35, 2022

Between 29 August 2022 and 2 September 2022 H & M Hennes & Mauritz AB (publ) (LEI code 529900O5RR7R39FRDM42) has repurchased in total 1,283,957 own B shares (ISIN: SE0000106270) as part of the share buyback programme initiated by the board of directors.The share buybacks form part of the SEK 3.0 billion share buyback programme that H&M announced on 29 June 2022. The share buyback programme, which runs between 29 June 2022 and 30 November 2022, is being carried out in accordance with Regulation (EU) No 596/2014 on market abuse (the Market Abuse Regulation – MAR) and Commission Delegated

SkartaNYAB Plc: Share issue directed to Power Forze AB's shareholders has been executed and trading in new shares begins

SkartaNYAB PlcCOMPANY ANNOUNCEMENT05 September 2022 at 09:30SkartaNYAB Plc: Share issue directed to Power Forze AB’s shareholders has been executed and trading in new shares begins SkartaNYAB Plc announced on 26 August 2022 that it arranges a directed share issue for Power Forze AB’s shareholders as a part of the transaction regarding the acquisition of all shares in Power Forze AB. Acquisition and decisions regarding the related share issue have been executed, and new shares have been registered in the Finnish Trade Register. Trading in new shares begins at Nasdaq First North Growth

BioStock: Stayble reaches important milestone – patient recruitment completed

Stayble Therapeutics recently recruited the last patient to the company’s phase IIb study with the drug candidate STA363 for discogenic chronic low back pain. The fact that the study is now fully recruited is in line with the communicated timetable to present study results by the end of 2023. The company’s CEO Andreas Gerward and CSO Anders Lehmann comments on the important milestone.Read the full article at biostock.se: https://www.biostock.se/en/2022/09/stayble-reaches-important-milestone-patient-recruitment-completed/ This is a press release from BioStock - Connecting Innovation &

Forxiga approved in China for CKD

5 September 2022 07:05 BST Forxiga approved in China for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes Approval marks the first SGLT2 inhibitor approved in China for chronic kidney disease in adult patients with and without type-2 diabetes AstraZeneca's Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in China to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease (ESKD), cardiovascular (CV) death and hospitalisation for

Inhalation Sciences receives new order worth 360,000 SEK from long-term global pharma client

(Stockholm, 5 September 2022) Inhalation Sciences AB (ISAB) has received a purchase order worth 360,000 SEK for development and required software update work from a long-term client, a leading global pharmaceutical company.The client has an extensive generics pipeline and robust R&D organisation. It has ISAB’s high-precision aerosol generation system PreciseInhale® installed in-house, as well as its in vitro lung simulation module DissolvIt®. Prior to purchase and installation, the client carried out a series of successful clinical research projects with Inhalation Research Services - ISAB’

ASSA ABLOY acquires Control iD in Brazil

ASSA ABLOY has signed an agreement to acquire Control iD, a leading developer of hardware and software solutions for access control and time & attendance in Brazil. “I look forward to welcoming Control iD and their employees into the ASSA ABLOY Group. Control iD is a strategic technological addition; reinforcing our current access control and biometrics offerings, providing complementary growth opportunities, and enabling us to grow our market leadership in emerging markets,” says Nico Delvaux, President and CEO of ASSA ABLOY. "Control iD’s focus on innovative biometric technologies,

Imfinzi approved in US for biliary tract cancer

5 September 2022 07:00 BST Imfinzi plus chemotherapy approved in the US as the first immunotherapy regimen for patients with advanced biliary tract cancer Approval based on TOPAZ-1 Phase III trial results, which showed Imfinzi combination reduced risk of death by 20% vs. chemotherapy alone AstraZeneca’s Imfinzi (durvalumab) has been approved in the US for the treatment of adult patients with locally advanced or metastatic biliary tract cancer (BTC) in combination with chemotherapy (gemcitabine plus cisplatin). The approval by the Food and Drug Administration (FDA) was based on

There are no items matching the current filter
There are no more items matching the current filter
Back to top